David A. Santos - EVP, Chief Commercial Officer at Rigel Pharmaceuticals Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Chief Commercial Officer
Stock Symbol
RIGL on Nasdaq
All Insider Reports
All Insider Reports

David A. Santos - trading volume in the past year for Rigel Pharmaceuticals Inc

Holdings reported by David A. Santos for Rigel Pharmaceuticals Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 349K $398K $1.14 Feb 5, 2024 Direct
Employee Stock Option (right to buy) 78.5K Feb 28, 2024 Direct Common Stock

Transactions reported by David A. Santos for Rigel Pharmaceuticals Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.